OpenNeedle Ask your own

Question explored with the scientific record

Tell ne about flasp

Oct 8, 2026 · 3 sources used · OpenNeedle synthesis
"Flasp" isn't a medical term in the retrieved evidence, so I can't tell you what it does.

The search returned studies on the Fas/Fas ligand pathway, which is a cell-death signaling system, not something called "flasp." If you meant "Fas ligand" or "FasL," the records show it's a protein that can trigger cell death and is involved in how tumors evade the immune system [1][2][3]. But I have no evidence about anything specifically named "flasp."

If you can clarify what you're asking about—a drug, a supplement, a condition, or a typo—I can give you a grounded answer. Without that, the honest response is that the evidence retrieved doesn't address your question.

My call: the term "flasp" is not defined in the retrieved records, so I cannot assess it. Confidence: not clear.

Keep digging

Sources used 3

  1. Addressing the “Fas Counterattack” Controversy: Blocking Fas Ligand Expression Suppresses Tumor Immune Evasion of Colon Cancer In vivo Cancer Research (2005) Thin

    Down-regulation of Fas ligand (FasL) expression in mouse colon tumor cells reduces in vivo tumor development and increases tumor-infiltrating lymphocyte influx, supporting FasL-mediated tumor immune evasion (the Fas counterattack) as a functional mechanism in colon cancer.

    DOI: 10.1158/0008-5472.can-05-1462
  2. Fas ligand expression and depletion of T-cell infiltration in astrocytic tumors Brain Tumor Pathology (2001) Thin

    This study investigates the expression of Fas ligand (FasL) in glioblastoma cell lines and human glioma specimens, revealing that FasL expression is associated with reduced T-cell infiltration, suggesting a mechanism for immune evasion in astrocytic tumors.

    DOI: 10.1007/BF02478923
  3. Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis Blood Cells, Molecules, and Diseases (2005) Thin

    This study investigates the role of tumor-derived exosomes expressing Fas ligand in mediating CD8+ T-cell apoptosis, suggesting a novel mechanism of immune evasion by tumors.

    DOI: 10.1016/j.bcmd.2005.07.001

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →